Cargando…
Azacitidine-Induced Pneumonitis in a Patient With Acute Myeloid Leukemia and Hyperleukocytosis
Chemotherapy-related toxicity is a complex aspect of oncologic care. Pulmonary toxicity, in particular, poses a significant challenge, as it can have diverse presentations and can closely mimic other common complications of cancer treatment, such as infections. Azacitidine is an agent widely employe...
Autores principales: | Litvin, Rafaella, Dasgupta, Mona, Saad Eldin, Mohamed, Shah, Mihir, Fakhran, Sherene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365400/ https://www.ncbi.nlm.nih.gov/pubmed/35967130 http://dx.doi.org/10.7759/cureus.26758 |
Ejemplares similares
-
BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019) -
Acute Myeloid Leukemia Complicated by Hyperleukocytosis and Leukostasis in the Emergency Department
por: Ngo, Ryan T, et al.
Publicado: (2021) -
Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia
por: Horvat, Nathan P, et al.
Publicado: (2022) -
Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation
por: Kong, Seom Gim, et al.
Publicado: (2014) -
Hyperleukocytosis in Childhood Acute Leukemia: Early Complications and Survival Outcomes
por: Kittivisuit, Sirinthip, et al.
Publicado: (2023)